Ikonisys SA

Research Ikonisys SA (ALIKO) on Bullrun: market cap EUR 24.40M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 24.40M.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2024EUR 1.01M-EUR 3.24M-EUR 1.37M70.8%-0.29EUR 25.08KEUR 4.13MEUR 14.25M
FY2023EUR 448.56K-EUR 2.27M-EUR 1.46M57.0%-0.23EUR 9.40KEUR 2.24MEUR 15.73M
FY2022EUR 616.87K-EUR 2.45M-EUR 2.01M70.3%-0.26EUR 93.99KEUR 1.34MEUR 17.67M
FY2021EUR 365.14K-EUR 571.27K-EUR 1.36M80.7%-0.06EUR 1.52MEUR 143.46KEUR 20.01M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-24EUR 24.40Mn/an/an/a

About Ikonisys SA

Ikonisys S.A., a cell-based diagnostics company, develops, produces, and markets medical diagnostic products for early and accurate detection of cancer diseases in the United States and Europe. It offers Ikoniscope Robotic Microscopes, including Ikoniscope20 that provides automated slide handling, slide scanning, and real-time image capture and analysis; and Ikoniscope20max that automates the fluorescence microscopy solution.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is Ikonisys SA's market cap?

Ikonisys SA's market capitalization is EUR 24.40M.

What does Ikonisys SA do?

Ikonisys S.A., a cell-based diagnostics company, develops, produces, and markets medical diagnostic products for early and accurate detection of cancer diseases in the United States and Europe. It offers Ikoniscope Robotic Microscopes, including Ikoniscope20 that provides automated slide handling, slide scanning, and real-time image capture and analysis; and Ikoniscope20max that automates the fluorescence microscopy solution.